TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07332182: MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee

Sponsor: Fin-Ceramica Faenza Spa · Phase: PHASE2 · Area: IMMUNOLOGY · Target Enrollment: 400 pts

Competing Trials Overlap

8 Active Trials

Excess Burn Exposure

$11,040,000

Rescue Site Savings

+$7,279,500

Unlock Full NCT07332182 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07332182 Rescue Dossier →